BOEHRINGER INGELHEIM INTERNATIONAL GMBH;BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG
发明人:
申请号：
EP08853791.5
公开号：
EP2225238B1
申请日:
2008.11.20
申请国别(地区):
EP
年份:
2014
代理人:
摘要：
Derivatives of 6,7-dihydro-5H-imidazo[1,2-alpha]imidazole-3-carboxylic acid amide exhibit good inhibitory effect upon the interaction of CAMs and Leukointegrins and are thus useful in the treatment of inflammatory disease.
